Tempest Therapeutics special meeting adjourned after proposal fell short of required votes
TPST•Special meeting results
Tempest Therapeutics held a reconvened special shareholder meeting on Aug. 17, 2026.
- Shareholders did not adopt a charter amendment to replace certain supermajority voting requirements.
- Shareholders also did not authorize a charter change to permit shareholder action by written consent.
- The meeting was adjourned to Sept. 15, 2026 to seek additional votes on the same charter amendment.
